Small Molecule API Market Research Report - Forecast to 2032

Small Molecule API Market Research Report Information By Types (Synthetic/Chemical API and Biological API), By Application (Cardiovascular, Oncology, Diabetes, and Immunological Disorders), By Manufacturing Method (In-House and Contract), and By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2032

ID: MRFR/Pharma/0279-CR | 109 Pages | Author: Rahul Gotadki | February 2021         

1 INTRODUCTION

1.1 DEFINITION 12

1.2 SCOPE OF STUDY 12

1.2.1 RESEARCH OBJECTIVE 12

1.2.2 ASSUMPTIONS & LIMITATIONS 13

1.2.2.1 ASSUMPTIONS 13

1.2.2.2 LIMITATIONS 13

1.3 MARKET STRUCTURE: 13

2 RESEARCH METHODOLOGY

2.1 RESEARCH PROCESS: 14

2.2 PRIMARY RESEARCH 15

2.3 SECONDARY RESEARCH: 15

3 MARKET DYNAMICS

3.1 DRIVERS 16

3.1.1 GROWING DEMAND FOR NEWLY DEVELOPED SMALL MOLECULES DRUGS 16

3.1.2 GROWING TREND OF OUTSOURCING 16

3.1.3 GROWING PHARMACEUTICAL INDUSTRY IN DEVELOPING NATIONS 17

3.2 RESTRAINTS 17

3.2.1 AUSTERITY MEASURES IN EUROPE 17

3.3 OPPORTUNITIES 17

3.4 MACROECONOMIC INDICATORS 18

4 MARKET FACTOR ANALYSIS

4.1 PORTERS FIVE FORCES MODEL 19

4.2 BARGAINING POWER OF SUPPLIERS 20

4.3 BARGAINING POWER OF BUYERS 20

4.4 THREAT OF NEW ENTRANTS 20

4.5 THREAT OF SUBSTITUTES 20

4.6 INTENSITY OF RIVALRY 20

5 SMALL MOLECULES API, BY TYPE

5.1 SYNTHETIC/CHEMICAL API 22

5.2 BIOLOGICAL API 23

6 SMALL MOLECULE API MARKET, BY APPLICATION

6.1 CARDIOVASCULAR 27

6.2 ONCOLOGY 28

6.3 DIABETES 29

6.4 IMMUNOLOGICAL DISORDERS 30

7 SMALL MOLECULE API MARKET, BY MANUFACTURING METHODS

7.1 IN-HOUSE MANUFACTURING 33

7.2 CONTRACT MANUFACTURING 34

7.2.1 INTRODUCTION 34

8 GLOBAL SMALL MOLECULE API MARKET, BY REGION

8.1 NORTH AMERICA 39

SMALL MOLECULES API, BY TYPE

SMALL MOLECULE API MARKET, BY APPLICATION

SMALL MOLECULE API MARKET, BY MANUFACTURING METHODS

8.1.1 INTRODUCTION 40

8.2 EUROPE 46

SMALL MOLECULES API, BY TYPE

SMALL MOLECULE API MARKET, BY APPLICATION

SMALL MOLECULE API MARKET, BY MANUFACTURING METHODS

8.2.1 INTRODUCTION 47

8.3 ASIA-PACIFIC 58

SMALL MOLECULES API, BY TYPE

SMALL MOLECULE API MARKET, BY APPLICATION

SMALL MOLECULE API MARKET, BY MANUFACTURING METHODS

8.3.1 INTRODUCTION 59

8.4 MIDDLE EAST & AFRICA 72

SMALL MOLECULES API, BY TYPE

SMALL MOLECULE API MARKET, BY APPLICATION

SMALL MOLECULE API MARKET, BY MANUFACTURING METHODS

8.4.1 INTRODUCTION 76

9 COMPETITIVE LANDSCAPE

9.1 MAJOR STRATEGIES ADOPTED BY MARKET PLAYERS 77

9.1.1 STRATEGIC PARTNERSHIP 78

9.1.2 MERGER & ACQUISITION 78

10 COMPANY PROFILE

10.1 ALBEMARLE CORPORATION 80

10.1.1 OVERVIEW 80

10.1.2 PRODUCT OVERVIEW 80

10.1.3 FINANCIALS 81

10.1.4 KEY DEVELOPMENTSS 81

10.2 ALLERGAN PLC 82

10.2.1 OVERVIEW 82

10.2.2 PRODUCT OVERVIEW 82

10.2.3 FINANCIALS 83

10.2.4 KEY DEVELOPMENTSS 83

10.3 AUROBINDO PHARMA 84

10.3.1 OVERVIEW 84

10.3.2 PRODUCT OVERVIEW 84

10.3.3 FINANCIALS 85

10.3.4 STRATEGIES 85

10.3.5 KEY DEVELOPMENTS 85

10.4 CAMBREX CORPORATION 86

10.4.1 OVERVIEW 86

10.4.2 PRODUCT OVERVIEW 86

10.4.3 FINANCIALS 87

10.4.4 KEY DEVELOPMENTS 87

10.5 DR. REDDY’S LABORATORIES LTD. 88

10.5.1 OVERVIEW 88

10.5.2 PRODUCT OVERVIEW 88

10.5.3 FINANCIALS 89

10.5.4 KEY DEVELOPMENTS 89

10.6 GLAXOSMITHKLINE PLC 90

10.6.1 OVERVIEW 90

10.6.2 PRODUCT OVERVIEW 90

10.6.3 FINANCIALS 91

10.6.4 STRATEGIES 91

10.6.5 KEY DEVELOPMENTS 92

10.7 LONZA 92

10.7.1 OVERVIEW 92

10.7.2 PRODUCT OVERVIEW 92

10.7.3 FINANCIALS 93

10.7.4 STRATEGIES 93

10.7.5 KEY DEVELOPMENTS 94

10.8 MERCK SHARP & DOHME CORP. 94

10.8.1 OVERVIEW 94

10.8.2 PRODUCT OVERVIEW 95

10.8.3 FINANCIAL 95

10.8.4 KEY DEVELOPMENTS 96

10.9 MYLAN N.V. 96

10.9.1 OVERVIEW 96

10.9.2 PRODUCT OVERVIEW 97

10.9.3 FINANCIALS 97

10.9.4 KEY DEVELOPMENTS 98

10.10 NOVARTIS AG 98

10.10.1 OVERVIEW 98

10.10.2 PRODUCT OVERVIEW 99

10.10.3 FINANCIALS 99

10.10.4 STRATEGIES 99

10.10.5 DEVELOPMENTS 100

10.11 PFIZER INC. 100

10.11.1 OVERVIEW 100

10.11.2 PRODUCT OVERVIEW 101

10.11.3 FINANCIALS 101

10.11.4 KEY DEVELOPMENTS 102

10.12 SIEGFRIED AG 102

10.12.1 OVERVIEW 102

10.12.2 PRODUCT OVERVIEW 102

10.12.3 FINANCIALS 103

10.12.4 KEY DEVELOPMENTS 103

10.13 SUN PHARMACEUTICAL INDUSTRIES LTD. 104

10.13.1 OVERVIEW 104

10.13.2 PRODUCT OVERVIEW 104

10.13.3 FINANCIALS 105

10.13.4 KEY DEVELOPMENTS 105

10.14 TEVA PHARMACEUTICAL INDUSTRIES LTD 106

10.14.1 OVERVIEW 106

10.14.2 PRODUCT OVERVIEW 106

10.14.3 FINANCIALS 107

10.14.4 STRATEGIES 107

10.14.5 KEY DEVELOPMENTS 108

11 LIST OF TABLES

TABLE 1 GLOBAL SMALL MOLECULE API MARKET, BY TYPE, 2020–2027 (USD MILLION) 22

TABLE 2 GLOBAL SYNTHETIC/CHEMICAL API MARKET, BY REGION, 2020–2027 (USD MILLION) 23

TABLE 3 GLOBAL BIOLOGICAL API MARKET, BY REGION, 2020–2027 (USD MILLION) 24

TABLE 4 GLOBAL SMALL MOLECULE API MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 26

TABLE 5 GLOBAL SMALL MOLECULE API MARKET: CARDIOVASCULAR, BY REGION, 2020–2027 (USD MILLION) 27

TABLE 6 GLOBAL SMALL MOLECULE API MARKET: ONCOLOGY, BY REGION, 2020–2027 (USD MILLION) 28

TABLE 7 GLOBAL SMALL MOLECULE API MARKET: DIABETES, BY REGION, 2020–2027 (USD MILLION) 29

TABLE 8 GLOBAL SMALL MOLECULE API MARKET: IMMUNOLOGICAL DISORDERS, BY REGION, 2020–2027 (USD MILLION) 30

TABLE 9 GLOBAL SMALL MOLECULE API MARKET, BY MANUFACTURING METHODS, 2020–2027 (USD MILLION) 32

TABLE 10 GLOBAL SMALL MOLECULE API MARKET, BY IN-HOUSE MANUFACTURING, 2020–2027 (USD MILLION) 33

TABLE 11 GLOBAL SMALL MOLECULE API MARKET, BY CONTRACT MANUFACTURING, 2020–2027 (USD MILLION) 34

TABLE 12 GLOBAL SMALL MOLECULE API MARKET, BY REGION, 2020–2027 (USD MILLION) 38

TABLE 13 NORTH AMERICA SMALL MOLECULE API MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 39

TABLE 14 NORTH AMERICA SMALL MOLECULE API MARKET, BY TYPE, 2020–2027 (USD MILLION) 40

TABLE 15 NORTH AMERICA SMALL MOLECULE API MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 41

TABLE 16 NORTH AMERICA SMALL MOLECULE API MARKET, BY MANUFACTURING METHOD, 2020–2027 (USD MILLION) 42

TABLE 17 US SMALL MOLECULE API MARKET, BY TYPE, 2020–2027 (USD MILLION) 43

TABLE 18 US SMALL MOLECULE API MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 44

TABLE 19 US SMALL MOLECULE API MARKET, BY MANUFACTURING METHODS, 2020–2027 (USD MILLION) 44

TABLE 20 CANADA SMALL MOLECULE API MARKET, BY TYPE, 2020–2027 (USD MILLION) 45

TABLE 21 CANADA SMALL MOLECULE API MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 45

TABLE 22 CANADA SMALL MOLECULE API MARKET, BY MANUFACTURING METHODS, 2020–2027 (USD MILLION) 46

TABLE 23 EUROPE SMALL MOLECULE API MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 47

TABLE 24 EUROPE SMALL MOLECULE API MARKET, BY TYPE, 2020–2027 (USD MILLION) 48

TABLE 25 EUROPE SMALL MOLECULE API MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 49

TABLE 26 EUROPE SMALL MOLECULE API MARKET, BY MANUFACTURING METHOD, 2020–2027 (USD MILLION) 50

TABLE 27 GERMANY SMALL MOLECULE API MARKET, BY TYPE, 2020–2027 (USD MILLION) 51

TABLE 28 GERMANY SMALL MOLECULE API MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 51

TABLE 29 GERMANY SMALL MOLECULE API MARKET, BY MANUFACTURING METHOD, 2020–2027 (USD MILLION) 52

TABLE 30 FRANCE SMALL MOLECULE API MARKET, BY TYPE, 2020–2027 (USD MILLION) 52

TABLE 31 FRANCE SMALL MOLECULE API MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 53

TABLE 32 FRANCE SMALL MOLECULE API MARKET, BY MANUFACTURING METHOD, 2020–2027 (USD MILLION) 53

TABLE 33 UK SMALL MOLECULE API MARKET, BY TYPE, 2020–2027 (USD MILLION) 54

TABLE 34 UK SMALL MOLECULE API MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 54

TABLE 35 UK SMALL MOLECULE API MARKET, BY MANUFACTURING METHOD, 2020–2027 (USD MILLION) 55

TABLE 36 ITALY SMALL MOLECULE API MARKET, BY TYPE, 2020–2027 (USD MILLION) 55

TABLE 37 ITALY SMALL MOLECULE API MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 56

TABLE 38 ITALY SMALL MOLECULE API MARKET, BY MANUFACTURING METHOD, 2020–2027 (USD MILLION) 56

TABLE 39 SPAIN SMALL MOLECULE API MARKET, BY TYPE, 2020–2027 (USD MILLION) 57

TABLE 40 SPAIN SMALL MOLECULE API MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 57

TABLE 41 SPAIN SMALL MOLECULE API MARKET, BY MANUFACTURING METHOD, 2020–2027 (USD MILLION) 58

TABLE 42 ASIA-PACIFIC SMALL MOLECULE API MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 59

TABLE 43 ASIA-PACIFIC SMALL MOLECULE API MARKET, BY TYPE, 2020–2027 (USD MILLION) 60

TABLE 44 ASIA-PACIFIC SMALL MOLECULE API MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 61

TABLE 45 ASIA-PACIFIC SMALL MOLECULE API MARKET, BY MANUFACTURING METHODS, 2020–2027 (USD MILLION) 62

TABLE 46 JAPAN SMALL MOLECULE API MARKET, BY TYPE, 2020–2027 (USD MILLION) 63

TABLE 47 JAPAN SMALL MOLECULE API MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 63

TABLE 48 JAPAN SMALL MOLECULE API MARKET, BY MANUFACTURING METHODS, 2020–2027 (USD MILLION) 64

TABLE 49 CHINA SMALL MOLECULE API MARKET, BY TYPE, 2020–2027 (USD MILLION) 64

TABLE 50 CHINA SMALL MOLECULE API MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 65

TABLE 51 CHINA SMALL MOLECULE API MARKET, BY MANUFACTURING METHODS, 2020–2027 (USD MILLION) 65

TABLE 52 INDIA SMALL MOLECULE API MARKET, BY TYPE, 2020–2027 (USD MILLION) 66

TABLE 53 INDIA SMALL MOLECULE API MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 66

TABLE 54 INDIA SMALL MOLECULE API MARKET, BY MANUFACTURING METHODS, 2020–2027 (USD MILLION) 67

TABLE 55 SOUTH KOREA SMALL MOLECULE API MARKET, BY TYPE, 2020–2027 (USD MILLION) 68

TABLE 56 SOUTH KOREA SMALL MOLECULE API MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 68

TABLE 57 SOUTH KOREA SMALL MOLECULE API MARKET, BY MANUFACTURING METHODS, 2020–2027 (USD MILLION) 69

TABLE 58 AUSTRALIA SMALL MOLECULE API MARKET, BY TYPE, 2020–2027 (USD MILLION) 70

TABLE 59 AUSTRALIA SMALL MOLECULE API MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 70

TABLE 60 AUSTRALIA SMALL MOLECULE API MARKET, BY MANUFACTURING METHODS, 2020–2027 (USD MILLION) 71

TABLE 61 MIDDLE EAST & AFRICA SMALL MOLECULE API MARKET, BY REGION, 2020–2027 (USD MILLION) 72

TABLE 62 MIDDLE EAST & AFRICA SMALL MOLECULE API MARKET, BY TYPE, 2020–2027 (USD MILLION) 73

TABLE 63 MIDDLE EAST & AFRICA SMALL MOLECULE API MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 74

TABLE 64 MIDDLE EAST & AFRICA SMALL MOLECULE API MARKET, BY MANUFACTURING METHODS, 2020–2027 (USD MILLION) 75

12 LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS 14

FIGURE 2 PORTERS FIVE FORCES MODEL 19

FIGURE 3 GLOBAL SMALL MOLECULE API MARKET, BY TYPE 22

FIGURE 4 GLOBAL SMALL MOLECULE API MARKET, BY APPLICATION 26

FIGURE 5 GLOBAL SMALL MOLECULE API MARKET, BY MANUFACTURING METHODS 32

FIGURE 6 CONTRACT MANUFACTURING ORGANIZATIONS: MARKET SHARE ANALYSIS (%) 35

FIGURE 7 GLOBAL SMALL MOLECULE API MARKET, BY REGION 38

FIGURE 8 NORTH AMERICA SMALL MOLECULE API MARKET, BY COUNTRY (%) 39

FIGURE 9 NORTH AMERICA SMALL MOLECULE API MARKET, BY TYPE 40

FIGURE 10 NORTH AMERICA SMALL MOLECULE API MARKET, BY APPLICATION 41

FIGURE 11 NORTH AMERICA SMALL MOLECULE API MARKET, BY MANUFACTURING METHOD 42

FIGURE 12 EUROPE SMALL MOLECULE API MARKET, BY COUNTRY (%) 46

FIGURE 13 EUROPE SMALL MOLECULE API MARKET, BY TYPE 48

FIGURE 14 EUROPE SMALL MOLECULE API MARKET, BY APPLICATION 49

FIGURE 15 EUROPE SMALL MOLECULE API MARKET, BY MANUFACTURING METHOD 50

FIGURE 16 ASIA-PACIFIC SMALL MOLECULE API MARKET, BY COUNTRY (%) 58

FIGURE 17 ASIA-PACIFIC SMALL MOLECULE API MARKET, BY TYPE 60

FIGURE 18 ASIA-PACIFIC SMALL MOLECULE API MARKET, BY APPLICATION 61

FIGURE 19 ASIA-PACIFIC SMALL MOLECULE API MARKET, BY MANUFACTURING METHODS 62

FIGURE 20 MIDDLE EAST & AFRICA SMALL MOLECULE API MARKET, BY COUNTRY (%) 72

FIGURE 21 MIDDLE EAST & AFRICA SMALL MOLECULE API MARKET, BY TYPE 73

FIGURE 22 MIDDLE EAST & AFRICA SMALL MOLECULE API MARKET, BY APPLICATION 74

FIGURE 23 MIDDLE EAST & AFRICA SMALL MOLECULE API MARKET, BY MANUFACTURING METHODS 75

FIGURE 24 GLOBAL SMALL MOLECULE API MARKET: COMPANY SHARE ANALYSIS, 2020 (%) 77

Market Segmentation Of Small Molecule API Market

Small Molecule API Type Outlook (USD Billion, 2019-2030)




  • Synthetic/Chemical API




  • Biological API




Small Molecule API Manufacturing Method Outlook (USD Billion, 2019-2030)




  • In-House




  • Contract




Small Molecule API Application Outlook (USD Billion, 2019-2030)




  • Cardiovascular




  • Oncology




  • Diabetes




  • Immunological Disorders




Small Molecule API Regional Outlook (USD Billion, 2019-2030)




  • North America Outlook (USD Billion, 2019-2030)




    • North America Small Molecule API by Type




      • Synthetic/Chemical API




      • Biological API






    • North America Small Molecule API by Manufacturing Method




      • In-House




      • Contract






    • North America Small Molecule API by Application




      • Cardiovascular




      • Oncology




      • Diabetes




      • Immunological Disorders






    • US Outlook (USD Billion, 2019-2030)




    • US Small Molecule API by Type




      • Synthetic/Chemical API




      • Biological API






    • US Small Molecule API by Manufacturing Method




      • In-House




      • Contract






    • US Small Molecule API by Application




      • Cardiovascular




      • Oncology




      • Diabetes




      • Immunological Disorders






    • CANADA Outlook (USD Billion, 2019-2030)




    • CANADA Small Molecule API by Type




      • Synthetic/Chemical API




      • Biological API






    • CANADA Small Molecule API by Manufacturing Method




      • In-House




      • Contract






    • CANADA Small Molecule API by Application




      • Cardiovascular




      • Oncology




      • Diabetes




      • Immunological Disorders








  • Europe Outlook (USD Billion, 2019-2030)




    • Europe Small Molecule API by Type




      • Synthetic/Chemical API




      • Biological API






    • Europe Small Molecule API by Manufacturing Method




      • In-House




      • Contract






    • Europe Small Molecule API by Application




      • Cardiovascular




      • Oncology




      • Diabetes




      • Immunological Disorders






    • Germany Outlook (USD Billion, 2019-2030)




    • Germany Small Molecule API by Type




      • Synthetic/Chemical API




      • Biological API






    • Germany Small Molecule API by Manufacturing Method




      • In-House




      • Contract






    • Germany Small Molecule API by Application




      • Cardiovascular




      • Oncology




      • Diabetes




      • Immunological Disorders






    • France Outlook (USD Billion, 2019-2030)




    • France Small Molecule API by Type




      • Synthetic/Chemical API




      • Biological API






    • France Small Molecule API by Manufacturing Method




      • In-House




      • Contract






    • France Small Molecule API by Application




      • Cardiovascular




      • Oncology




      • Diabetes




      • Immunological Disorders






    • UK Outlook (USD Billion, 2019-2030)




    • UK Small Molecule API by Type




      • Synthetic/Chemical API




      • Biological API






    • UK Small Molecule API by Manufacturing Method




      • In-House




      • Contract






    • UK Small Molecule API by Application




      • Cardiovascular




      • Oncology




      • Diabetes




      • Immunological Disorders






    • ITALY Outlook (USD Billion, 2019-2030)




    • ITALY Small Molecule API by Type




      • Synthetic/Chemical API




      • Biological API






    • ITALY Small Molecule API by Manufacturing Method




      • In-House




      • Contract






    • ITALY Small Molecule API by Application




      • Cardiovascular




      • Oncology




      • Diabetes




      • Immunological Disorders







Leading companies partner with us for data-driven Insights.
Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response
Invalid